Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Air pollution affects genes involved in sperm development

18 Jul 2026 bởi

Men who are exposed to air pollution may experience changes in genes that are relevant to sperm development, potentially affecting fertility, pregnancy outcomes, and even offspring health, suggests a recent study.

Air pollution affects genes involved in sperm development

Coffee drinking may promote liver health

High coffee intake may have protective effects on the liver, with reduced risk of cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, as reported in a study.

Coffee drinking may promote liver health

Lung transplant shows signal of benefit in select lung cancer patients

For a carefully selected group of patients with medically refractory, lung-limited, stage IV non-small cell lung cancer (NSCLC), bilateral lung transplant appears beneficial, being associated with favourable early survival outcomes, as shown in a study.

Lung transplant shows signal of benefit in select lung cancer patients

Higher medial-to-lateral sBMD tied to OA knee pain presence, progression

A higher ratio of medial-to-lateral subchondral bone mineral density (sBMD) appears predictive of the presence and progression of knee pain in people with osteoarthritis (OA), suggests a study.

Higher medial-to-lateral sBMD tied to OA knee pain presence, progression

Early-onset RIL in glioblastoma patients treated with STUPP warrants monitoring

Nearly a third of glioblastoma patients treated with standard radiotherapy plus temozolomide (STUPP protocol) suffer early-onset radiation induced leukoencephalopathy (RIL), which is linked to early cognitive and functional decline, according to a study.

Early-onset RIL in glioblastoma patients treated with STUPP warrants monitoring

Novel BTK inhibitor on par with ocrelizumab in reducing disability progression in PPMS

The investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib demonstrates its noninferiority to ocrelizumab in reducing the risk of disability progression in patients with primary progressive multiple sclerosis (PPMS) in the phase III FENtrepid study.

Novel BTK inhibitor on par with ocrelizumab in reducing disability progression in PPMS

17 Jul 2026

Does MS relapse after stopping ponesimod?

In a post hoc analysis of the OPTIMUM* long-term extension (OPTIMUM-LTE) study, discontinuation of ponesimod did not lead to a clinically meaningful disease reactivation or rebound effect in patients with relapsing multiple sclerosis (MS).

Does MS relapse after stopping ponesimod?